Skip to main content
Top
Published in: Basic Research in Cardiology 2/2010

01-03-2010 | Original Contribution

Transcriptional regulation of Pim-1 kinase in vascular smooth muscle cells and its role for proliferation

Authors: Manuela Willert, Antje Augstein, David M. Poitz, Alexander Schmeisser, Ruth H. Strasser, Ruediger Christian Braun-Dullaeus

Published in: Basic Research in Cardiology | Issue 2/2010

Login to get access

Abstract

The Ser/Thr-protein kinase Pim-1 has been discovered as a novel transducer of survival- and cell cycle promoting signals in the hematopoietic cell system. Although its significance for proliferation of vascular smooth muscle cells (VSMC) in vitro and neointima formation in vivo has been suggested recently, the mechanism has barely been characterized. This study aimed to foster the understanding of Pim-1 expression and regulation in murine VSMC in response to factors typically present within the atherosclerotic plaque. While oxidative stress, VEGF-A165 and angiotensin II did not have any effect on Pim-1 expression, VSMC strongly increased (3-fold) Pim-1 mRNA upon stimulation with PDGFbb, followed by its protein upregulation. Half life of Pim-1 RNA and protein were determined to be 25 min and 6 h, respectively. PDGFbb induced a strong, 10-fold increase in BrdU-uptake, a marker of proliferation. This was effectively blocked by either Pim-1-specific inhibitor quercetagetin or adenovirally introduced Pim-1 shRNA. We further identified the signaling pathways linking PDGFbb to Pim-1 in VSMC: as expected, we determined transcriptional stimulation of Pim-1 via Janus-activated kinase (Jak), but also an additional pathway involving protein kinase C (PKC) and the mitogen-activated protein kinase Mek1/2. Blockade of Akt signaling did, however, not interfere with Pim-1 upregulation, suggesting an independence of either survival system. PDGFbb-induced proliferation of VSMC is partly attributed to transcriptionally upregulated Pim-1 and was assigned to distinct cell signaling. Our findings help to understand the fundamental processes of vasculoproliferative diseases thus opening avenues for its prevention and treatment.
Appendix
Available only for authorised users
Literature
1.
go back to reference Aho TL, Lund RJ, Ylikoski EK, Matikainen S, Lahesmaa R, Koskinen PJ (2005) Expression of human Pim family genes is selectively up-regulated by cytokines promoting T helper type 1, but not T helper type 2, cell differentiation. Immunology 116:82–88CrossRefPubMed Aho TL, Lund RJ, Ylikoski EK, Matikainen S, Lahesmaa R, Koskinen PJ (2005) Expression of human Pim family genes is selectively up-regulated by cytokines promoting T helper type 1, but not T helper type 2, cell differentiation. Immunology 116:82–88CrossRefPubMed
2.
go back to reference Amaravadi R, Thompson CB (2005) The survival kinases Akt and Pim as potential pharmacological targets. J Clin Invest 115:2618–2624CrossRefPubMed Amaravadi R, Thompson CB (2005) The survival kinases Akt and Pim as potential pharmacological targets. J Clin Invest 115:2618–2624CrossRefPubMed
3.
go back to reference Bachmann M, Hennemann H, Xing PX, Hoffmann I, Moroy T (2004) The Oncogenic Serine/Threonine Kinase Pim-1 Phosphorylates and Inhibits the Activity of Cdc25C-associated Kinase 1 (C-TAK1): a novel role for Pim-1 at the G2/M cell cycle checkpoint. J Biol Chem 279:48319–48328CrossRefPubMed Bachmann M, Hennemann H, Xing PX, Hoffmann I, Moroy T (2004) The Oncogenic Serine/Threonine Kinase Pim-1 Phosphorylates and Inhibits the Activity of Cdc25C-associated Kinase 1 (C-TAK1): a novel role for Pim-1 at the G2/M cell cycle checkpoint. J Biol Chem 279:48319–48328CrossRefPubMed
4.
go back to reference Banai S, Wolf Y, Golomb G, Pearle A, Waltenberger J, Fishbein I, Schneider A, Gazit A, Perez L, Huber R, Lazarovichi G, Rabinovich L, Levitzki A, Gertz SD (1998) PDGF-receptor tyrosine kinase blocker AG1295 selectively attenuates smooth muscle cell growth in vitro and reduces neointimal formation after balloon angioplasty in swine. Circulation 97:1960–1969PubMed Banai S, Wolf Y, Golomb G, Pearle A, Waltenberger J, Fishbein I, Schneider A, Gazit A, Perez L, Huber R, Lazarovichi G, Rabinovich L, Levitzki A, Gertz SD (1998) PDGF-receptor tyrosine kinase blocker AG1295 selectively attenuates smooth muscle cell growth in vitro and reduces neointimal formation after balloon angioplasty in swine. Circulation 97:1960–1969PubMed
5.
go back to reference Berra E, az-Meco MT, Dominguez I, Municio MM, Sanz L, Lozano J, Chapkin RS, Moscat J (1993) Protein kinase C [zeta] isoform is critical for mitogenic signal transduction. Cell 74:555–563CrossRefPubMed Berra E, az-Meco MT, Dominguez I, Municio MM, Sanz L, Lozano J, Chapkin RS, Moscat J (1993) Protein kinase C [zeta] isoform is critical for mitogenic signal transduction. Cell 74:555–563CrossRefPubMed
6.
go back to reference Buckley AR (2000) Transcriptional regulation of Pim-1 by prolactin: independence of a requirement for Jak2/Stat signaling. J Neuroimmunol 109:40–46CrossRefPubMed Buckley AR (2000) Transcriptional regulation of Pim-1 by prolactin: independence of a requirement for Jak2/Stat signaling. J Neuroimmunol 109:40–46CrossRefPubMed
7.
go back to reference Chittenden TW, Sherman JA, Xiong F, Hall AE, Lanahan AA, Taylor JM, Duan H, Pearlman JD, Moore JH, Schwartz SM, Simons M (2006) Transcriptional profiling in coronary artery disease: indications for novel markers of coronary collateralization. Circulation 114:1811–1820CrossRefPubMed Chittenden TW, Sherman JA, Xiong F, Hall AE, Lanahan AA, Taylor JM, Duan H, Pearlman JD, Moore JH, Schwartz SM, Simons M (2006) Transcriptional profiling in coronary artery disease: indications for novel markers of coronary collateralization. Circulation 114:1811–1820CrossRefPubMed
8.
go back to reference Cuypers HT, Selten G, Quint W, Zijlstra M, Maandag ER, Boelens W, van Wezenbeek P, Melief C, Berns A (1984) Murine leukemia virus-induced T-cell lymphomagenesis: integration of proviruses in a distinct chromosomal region. Cell 37:141–150CrossRefPubMed Cuypers HT, Selten G, Quint W, Zijlstra M, Maandag ER, Boelens W, van Wezenbeek P, Melief C, Berns A (1984) Murine leukemia virus-induced T-cell lymphomagenesis: integration of proviruses in a distinct chromosomal region. Cell 37:141–150CrossRefPubMed
9.
go back to reference Dixon BS, Sharma RV, Dickerson T, Fortune J (1994) Bradykinin and angiotensin II: activation of protein kinase C in arterial smooth muscle. Am J Physiol Cell Physiol 266:C1406–C1420 Dixon BS, Sharma RV, Dickerson T, Fortune J (1994) Bradykinin and angiotensin II: activation of protein kinase C in arterial smooth muscle. Am J Physiol Cell Physiol 266:C1406–C1420
10.
go back to reference Dwivedi A, Sala-Newby GB, George SJ (2008) Regulation of cell-matrix contacts and beta-catenin signaling in VSMC by integrin-linked kinase: implications for intimal thickening. Basic Res Cardiol 103:244–256CrossRefPubMed Dwivedi A, Sala-Newby GB, George SJ (2008) Regulation of cell-matrix contacts and beta-catenin signaling in VSMC by integrin-linked kinase: implications for intimal thickening. Basic Res Cardiol 103:244–256CrossRefPubMed
11.
go back to reference Dzau VJ, Braun-Dullaeus RC, Sedding DG (2002) Vascular proliferation and atherosclerosis: new perspectives and therapeutic strategies. Nat Med 8:1249–1256CrossRefPubMed Dzau VJ, Braun-Dullaeus RC, Sedding DG (2002) Vascular proliferation and atherosclerosis: new perspectives and therapeutic strategies. Nat Med 8:1249–1256CrossRefPubMed
12.
go back to reference Erbel C, Sato K, Meyer FB, Kopecky SL, Frye RL, Goronzy JJ, Weyand CM (2007) Functional profile of activated dendritic cells in unstable atherosclerotic plaque. Basic Res Cardiol 102:123–132CrossRefPubMed Erbel C, Sato K, Meyer FB, Kopecky SL, Frye RL, Goronzy JJ, Weyand CM (2007) Functional profile of activated dendritic cells in unstable atherosclerotic plaque. Basic Res Cardiol 102:123–132CrossRefPubMed
13.
go back to reference Fox CJ, Hammerman PS, Thompson CB (2005) The Pim kinases control rapamycin-resistant T cell survival and activation. J Exp Med 201:259–266CrossRefPubMed Fox CJ, Hammerman PS, Thompson CB (2005) The Pim kinases control rapamycin-resistant T cell survival and activation. J Exp Med 201:259–266CrossRefPubMed
14.
go back to reference Frank GD, Inagami T (2006) PDGF induces a ROS and Src kinase-dependent PKC-delta Tyr-311 phosphorylation promoting vascular smooth muscle cell growth and proliferation. FASEB J 20:LB16–LB1a Frank GD, Inagami T (2006) PDGF induces a ROS and Src kinase-dependent PKC-delta Tyr-311 phosphorylation promoting vascular smooth muscle cell growth and proliferation. FASEB J 20:LB16–LB1a
15.
go back to reference Hammerman PS, Fox CJ, Birnbaum MJ, Thompson CB (2005) Pim and Akt oncogenes are independent regulators of hematopoietic cell growth and survival. Blood 105:4477–4483CrossRefPubMed Hammerman PS, Fox CJ, Birnbaum MJ, Thompson CB (2005) Pim and Akt oncogenes are independent regulators of hematopoietic cell growth and survival. Blood 105:4477–4483CrossRefPubMed
16.
go back to reference Holder S, Zemskova M, Zhang C, Tabrizizad M, Bremer R, Neidigh JW, Lilly MB (2007) Characterization of a potent and selective small-molecule inhibitor of the Pim 1 kinase. Mol Cancer Ther 6:163–172CrossRefPubMed Holder S, Zemskova M, Zhang C, Tabrizizad M, Bremer R, Neidigh JW, Lilly MB (2007) Characterization of a potent and selective small-molecule inhibitor of the Pim 1 kinase. Mol Cancer Ther 6:163–172CrossRefPubMed
17.
go back to reference Hoover DS, Wingett DG, Zhang J, Reeves R, Magnuson NS (1997) Pim-1 protein expression is regulated by its 5′-untranslated region and translation initiation factor elF-4E. Cell Growth Differ 8:1371–1380PubMed Hoover DS, Wingett DG, Zhang J, Reeves R, Magnuson NS (1997) Pim-1 protein expression is regulated by its 5′-untranslated region and translation initiation factor elF-4E. Cell Growth Differ 8:1371–1380PubMed
18.
go back to reference Inoue M, Itoh H, Ueda M, Naruko T, Kojima A, Komatsu R, Doi K, Ogawa Y, Tamura N, Takaya K, Igaki T, Yamashita J, Chun TH, Masatsugu K, Becker AE, Nakao K (1998) Vascular endothelial growth factor (VEGF) expression in human coronary atherosclerotic lesions: possible pathophysiological significance of VEGF in progression of atherosclerosis. Circulation 98:2108–2116PubMed Inoue M, Itoh H, Ueda M, Naruko T, Kojima A, Komatsu R, Doi K, Ogawa Y, Tamura N, Takaya K, Igaki T, Yamashita J, Chun TH, Masatsugu K, Becker AE, Nakao K (1998) Vascular endothelial growth factor (VEGF) expression in human coronary atherosclerotic lesions: possible pathophysiological significance of VEGF in progression of atherosclerosis. Circulation 98:2108–2116PubMed
19.
go back to reference Jones AV, Kreil S, Zoi K, Waghorn K, Curtis C, Zhang L, Score J, Seear R, Chase AJ, Grand FH, White H, Zoi C, Loukopoulos D, Terpos E, Vervessou EC, Schultheis B, Emig M, Ernst T, Lengfelder E, Hehlmann R, Hochhaus A, Oscier D, Silver RT, Reiter A, Cross NCP (2005) Widespread occurrence of the JAK2 V617F mutation in chronic myeloproliferative disorders. Blood 106:2162–2168CrossRefPubMed Jones AV, Kreil S, Zoi K, Waghorn K, Curtis C, Zhang L, Score J, Seear R, Chase AJ, Grand FH, White H, Zoi C, Loukopoulos D, Terpos E, Vervessou EC, Schultheis B, Emig M, Ernst T, Lengfelder E, Hehlmann R, Hochhaus A, Oscier D, Silver RT, Reiter A, Cross NCP (2005) Widespread occurrence of the JAK2 V617F mutation in chronic myeloproliferative disorders. Blood 106:2162–2168CrossRefPubMed
20.
go back to reference Kalsch T, Elmas E, Nguyen XD, Suvajac N, Kluter H, Borggrefe M, Dempfle CE (2007) Endotoxin-induced effects on platelets and monocytes in an in vivo model of inflammation. Basic Res Cardiol 102:460–466CrossRefPubMed Kalsch T, Elmas E, Nguyen XD, Suvajac N, Kluter H, Borggrefe M, Dempfle CE (2007) Endotoxin-induced effects on platelets and monocytes in an in vivo model of inflammation. Basic Res Cardiol 102:460–466CrossRefPubMed
21.
go back to reference Katakami N, Kaneto H, Hao H, Umayahara Y, Fujitani Y, Sakamoto K, Si Gorogawa, Yasuda T, Kawamori D, Kajimoto Y, Matsuhisa M, Yutani C, Hori M, Yamasaki Y (2004) Role of Pim-1 in smooth muscle cell proliferation. J Biol Chem 279:54742–54749CrossRefPubMed Katakami N, Kaneto H, Hao H, Umayahara Y, Fujitani Y, Sakamoto K, Si Gorogawa, Yasuda T, Kawamori D, Kajimoto Y, Matsuhisa M, Yutani C, Hori M, Yamasaki Y (2004) Role of Pim-1 in smooth muscle cell proliferation. J Biol Chem 279:54742–54749CrossRefPubMed
22.
go back to reference Kralovics R, Passamonti F, Buser AS, Teo SS, Tiedt R, Passweg JR, Tichelli A, Cazzola M, Skoda RC (2005) A gain-of-function mutation of JAK2 in myeloproliferative disorders. N Engl J Med 352:1779–1790CrossRefPubMed Kralovics R, Passamonti F, Buser AS, Teo SS, Tiedt R, Passweg JR, Tichelli A, Cazzola M, Skoda RC (2005) A gain-of-function mutation of JAK2 in myeloproliferative disorders. N Engl J Med 352:1779–1790CrossRefPubMed
23.
go back to reference Krishnan N, Pan H, Buckley DJ, Buckley A (2003) Prolactin-regulated Pim-1 transcription: identification of critical promoter elements and Akt signaling. Endocrine 20:123–130CrossRefPubMed Krishnan N, Pan H, Buckley DJ, Buckley A (2003) Prolactin-regulated Pim-1 transcription: identification of critical promoter elements and Akt signaling. Endocrine 20:123–130CrossRefPubMed
24.
25.
go back to reference Losman JA, Chen XP, Vuong BQ, Fay S, Rothman PB (2003) Protein phosphatase 2A regulates the stability of Pim protein kinases. J Biol Chem 278:4800–4805CrossRefPubMed Losman JA, Chen XP, Vuong BQ, Fay S, Rothman PB (2003) Protein phosphatase 2A regulates the stability of Pim protein kinases. J Biol Chem 278:4800–4805CrossRefPubMed
26.
go back to reference Martiny-Baron G, Kazanietz MG, Mischak H, Blumberg PM, Kochs G, Hug H, Marme D, Schachtele C (1993) Selective inhibition of protein kinase C isozymes by the indolocarbazole Go 6976. J Biol Chem 268:9194–9197PubMed Martiny-Baron G, Kazanietz MG, Mischak H, Blumberg PM, Kochs G, Hug H, Marme D, Schachtele C (1993) Selective inhibition of protein kinase C isozymes by the indolocarbazole Go 6976. J Biol Chem 268:9194–9197PubMed
27.
go back to reference Mikkers H, Nawijn M, Allen J, Brouwers C, Verhoeven E, Jonkers J, Berns A (2004) Mice deficient for all Pim kinases display reduced body size and impaired responses to hematopoietic growth factors. Mol Cell Biol 24:6104–6115CrossRefPubMed Mikkers H, Nawijn M, Allen J, Brouwers C, Verhoeven E, Jonkers J, Berns A (2004) Mice deficient for all Pim kinases display reduced body size and impaired responses to hematopoietic growth factors. Mol Cell Biol 24:6104–6115CrossRefPubMed
28.
go back to reference Miura O, Miura Y, Nakamura N, Quelle FW, Witthuhn BA, Ihle JN, Aoki N (1994) Induction of tyrosine phosphorylation of Vav and expression of Pim-1 correlates with Jak2-mediated growth signaling from the erythropoietin receptor. Blood 84:4135–4141PubMed Miura O, Miura Y, Nakamura N, Quelle FW, Witthuhn BA, Ihle JN, Aoki N (1994) Induction of tyrosine phosphorylation of Vav and expression of Pim-1 correlates with Jak2-mediated growth signaling from the erythropoietin receptor. Blood 84:4135–4141PubMed
29.
go back to reference Mizuno K, Shirogane T, Shinohara A, Iwamatsu A, Hibi M, Hirano T (2001) Regulation of Pim-1 by Hsp90. Biochem Biophys Res Commun 281:663–669CrossRefPubMed Mizuno K, Shirogane T, Shinohara A, Iwamatsu A, Hibi M, Hirano T (2001) Regulation of Pim-1 by Hsp90. Biochem Biophys Res Commun 281:663–669CrossRefPubMed
30.
go back to reference Nagarajan L, Narayana L (1993) Transcriptional attenuation of Pim-1 gene. Biochem Biophys Res Commun 190:435–439CrossRefPubMed Nagarajan L, Narayana L (1993) Transcriptional attenuation of Pim-1 gene. Biochem Biophys Res Commun 190:435–439CrossRefPubMed
31.
go back to reference Okazaki J, Mawatari K, Liu B, Kent KC (2000) The effect of protein kinase C and its alpha subtype on human vascular smooth muscle cell proliferation, migration and fibronectin production. Surgery 128:192–197CrossRefPubMed Okazaki J, Mawatari K, Liu B, Kent KC (2000) The effect of protein kinase C and its alpha subtype on human vascular smooth muscle cell proliferation, migration and fibronectin production. Surgery 128:192–197CrossRefPubMed
32.
go back to reference Padma R, Nagarajan L (1991) The human Pim-1 gene product is a protein serine kinase. Cancer Res 51:2486–2489PubMed Padma R, Nagarajan L (1991) The human Pim-1 gene product is a protein serine kinase. Cancer Res 51:2486–2489PubMed
33.
go back to reference Palaty CK, Kalmar G, Tai G, Oh S, Amankawa L, Affolter M, Aebersold R, Pelech SL (1997) Identification of the autophosphorylation sites of the Xenopus laevis Pim-1 Proto-oncogene-encoded protein kinase. J Biol Chem 272:10514–10521CrossRefPubMed Palaty CK, Kalmar G, Tai G, Oh S, Amankawa L, Affolter M, Aebersold R, Pelech SL (1997) Identification of the autophosphorylation sites of the Xenopus laevis Pim-1 Proto-oncogene-encoded protein kinase. J Biol Chem 272:10514–10521CrossRefPubMed
34.
go back to reference Panek RL, Dahring TK, Olszewski BJ, Keiser JA (1997) PDGF receptor protein tyrosine kinase expression in the balloon-injured rat carotid artery. Arterioscler Thromb Vasc Biol 17:1283–1288PubMed Panek RL, Dahring TK, Olszewski BJ, Keiser JA (1997) PDGF receptor protein tyrosine kinase expression in the balloon-injured rat carotid artery. Arterioscler Thromb Vasc Biol 17:1283–1288PubMed
35.
go back to reference Parmentier JH, Smelcer P, Pavicevic Z, Basic E, Idrizovic A, Estes A, Malik KU (2003) PKC-{zeta} mediates norepinephrine-induced phospholipase D activation and cell proliferation in VSMC. Hypertension 41:794–800CrossRefPubMed Parmentier JH, Smelcer P, Pavicevic Z, Basic E, Idrizovic A, Estes A, Malik KU (2003) PKC-{zeta} mediates norepinephrine-induced phospholipase D activation and cell proliferation in VSMC. Hypertension 41:794–800CrossRefPubMed
36.
go back to reference Patel NA, Chalfant CE, Yamamoto M, Watson JE, Eichler DC, Cooper DR (1999) Acute hyperglycemia regulates transcription and posttranscriptional stability of PKC-II mRNA in vascular smooth muscle cells. FASEB J 13:103–113PubMed Patel NA, Chalfant CE, Yamamoto M, Watson JE, Eichler DC, Cooper DR (1999) Acute hyperglycemia regulates transcription and posttranscriptional stability of PKC-II mRNA in vascular smooth muscle cells. FASEB J 13:103–113PubMed
37.
go back to reference Qian KC, Wang L, Hickey ER, Studts J, Barringer K, Peng C, Kronkaitis A, Li J, White A, Mische S, Farmer B (2005) Structural basis of constitutive activity and a unique nucleotide binding mode of human Pim-1 kinase. J Biol Chem 280:6130–6137CrossRefPubMed Qian KC, Wang L, Hickey ER, Studts J, Barringer K, Peng C, Kronkaitis A, Li J, White A, Mische S, Farmer B (2005) Structural basis of constitutive activity and a unique nucleotide binding mode of human Pim-1 kinase. J Biol Chem 280:6130–6137CrossRefPubMed
38.
go back to reference Robin P, Boulven I, Bole-Feysot C, Tanfin Z, Leiber D (2004) Contribution of PKC-dependent and -independent processes in temporal ERK regulation by ET-1, PDGF, and EGF in rat myometrial cells. Cell Physiol 286:C798–C806CrossRef Robin P, Boulven I, Bole-Feysot C, Tanfin Z, Leiber D (2004) Contribution of PKC-dependent and -independent processes in temporal ERK regulation by ET-1, PDGF, and EGF in rat myometrial cells. Cell Physiol 286:C798–C806CrossRef
41.
go back to reference Ross R, Glomset JA (1973) Atherosclerosis and the arterial smooth muscle cell. Science 180:1332–1339CrossRefPubMed Ross R, Glomset JA (1973) Atherosclerosis and the arterial smooth muscle cell. Science 180:1332–1339CrossRefPubMed
42.
go back to reference Selten G, Cuypers HT, Berns A (1985) Proviral activation of the putative oncogene Pim-1 in MuLV induced T-cell lymphomas. EMBO J 4:1793–1798PubMed Selten G, Cuypers HT, Berns A (1985) Proviral activation of the putative oncogene Pim-1 in MuLV induced T-cell lymphomas. EMBO J 4:1793–1798PubMed
43.
go back to reference Shirogane T, Fukada T, Muller JM, Shima DT, Hibi M, Hirano T (1999) Synergistic roles for Pim-1 and c-Myc in STAT3-mediated cell cycle progression and antiapoptosis. Immunity 11:709–719CrossRefPubMed Shirogane T, Fukada T, Muller JM, Shima DT, Hibi M, Hirano T (1999) Synergistic roles for Pim-1 and c-Myc in STAT3-mediated cell cycle progression and antiapoptosis. Immunity 11:709–719CrossRefPubMed
44.
go back to reference Stout BA, Bates ME, Liu LY, Farrington NN, Bertics PJ (2004) IL-5 and granulocyte–macrophage colony-stimulating factor activate STAT3 and STAT5 and promote Pim-1 and cyclin D3 protein expression in human eosinophils. J Immunol 173:6409–6417PubMed Stout BA, Bates ME, Liu LY, Farrington NN, Bertics PJ (2004) IL-5 and granulocyte–macrophage colony-stimulating factor activate STAT3 and STAT5 and promote Pim-1 and cyclin D3 protein expression in human eosinophils. J Immunol 173:6409–6417PubMed
45.
go back to reference Wang Z, Bhattacharya N, Mixter PF, Wei W, Sedivy J, Magnuson NS (2002) Phosphorylation of the cell cycle inhibitor p21Cip1/WAF1 by Pim-1 kinase. Biochim Biophys Acta Mol Cell Res 1593:45–55CrossRef Wang Z, Bhattacharya N, Mixter PF, Wei W, Sedivy J, Magnuson NS (2002) Phosphorylation of the cell cycle inhibitor p21Cip1/WAF1 by Pim-1 kinase. Biochim Biophys Acta Mol Cell Res 1593:45–55CrossRef
46.
go back to reference Wingett D, Reeves R, Magnuson NS (1991) Stability changes in Pim-1 proto-oncogene mRNA after mitogen stimulation of normal lymphocytes. J Immunol 147:3653–3659PubMed Wingett D, Reeves R, Magnuson NS (1991) Stability changes in Pim-1 proto-oncogene mRNA after mitogen stimulation of normal lymphocytes. J Immunol 147:3653–3659PubMed
47.
go back to reference Yamamoto M, cevedo-Duncan M, Chalfant CE, Patel NA, Watson JE, Cooper DR (1998) The roles of protein kinase C beta I and beta II in vascular smooth muscle cell proliferation. Exp Cell Res 240:349–358CrossRefPubMed Yamamoto M, cevedo-Duncan M, Chalfant CE, Patel NA, Watson JE, Cooper DR (1998) The roles of protein kinase C beta I and beta II in vascular smooth muscle cell proliferation. Exp Cell Res 240:349–358CrossRefPubMed
48.
go back to reference Yip-Schneider MT, Horie M, Broxmeyer HE (1995) Transcriptional induction of Pim-1 protein kinase gene expression by interferon gamma and posttranscriptional effects on costimulation with steel factor. Blood 85:3494–3502PubMed Yip-Schneider MT, Horie M, Broxmeyer HE (1995) Transcriptional induction of Pim-1 protein kinase gene expression by interferon gamma and posttranscriptional effects on costimulation with steel factor. Blood 85:3494–3502PubMed
49.
go back to reference Zhang Y, Wang Z, Magnuson NS (2007) Pim-1 kinase-dependent phosphorylation of p21Cip1/WAF1 regulates its stability and cellular localization in H1299 Cells. Mol Cancer Res 5:909–922CrossRefPubMed Zhang Y, Wang Z, Magnuson NS (2007) Pim-1 kinase-dependent phosphorylation of p21Cip1/WAF1 regulates its stability and cellular localization in H1299 Cells. Mol Cancer Res 5:909–922CrossRefPubMed
50.
go back to reference Zhao Y, Liu J, Li L, Liu L, Wu L (2005) Role of Ras/PKC[zeta]/MEK/ERK1/2 signaling pathway in angiotensin II-induced vascular smooth muscle cell proliferation. Regul Pept 128:43–50CrossRefPubMed Zhao Y, Liu J, Li L, Liu L, Wu L (2005) Role of Ras/PKC[zeta]/MEK/ERK1/2 signaling pathway in angiotensin II-induced vascular smooth muscle cell proliferation. Regul Pept 128:43–50CrossRefPubMed
51.
go back to reference Zippo A, De Robertis A, Bardelli M, Galvagni F, Oliviero S (2004) Identification of Flk-1 target genes in vasculogenesis: Pim-1 is required for endothelial and mural cell differentiation in vitro. Blood 103:4536–4544CrossRefPubMed Zippo A, De Robertis A, Bardelli M, Galvagni F, Oliviero S (2004) Identification of Flk-1 target genes in vasculogenesis: Pim-1 is required for endothelial and mural cell differentiation in vitro. Blood 103:4536–4544CrossRefPubMed
Metadata
Title
Transcriptional regulation of Pim-1 kinase in vascular smooth muscle cells and its role for proliferation
Authors
Manuela Willert
Antje Augstein
David M. Poitz
Alexander Schmeisser
Ruth H. Strasser
Ruediger Christian Braun-Dullaeus
Publication date
01-03-2010
Publisher
D. Steinkopff-Verlag
Published in
Basic Research in Cardiology / Issue 2/2010
Print ISSN: 0300-8428
Electronic ISSN: 1435-1803
DOI
https://doi.org/10.1007/s00395-009-0055-x

Other articles of this Issue 2/2010

Basic Research in Cardiology 2/2010 Go to the issue